Jean Claude Deharo

TL;DR: 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : The Task Force on cardiac paced and resynchronized therapy of the European Society of Cardiology developed in collaboration with the European Heart Rhythm Association.

TL;DR: Fred M. Kusumoto,MD, FHRS, FACC, Chair, Mark H. Schoenfeld, MD, F hrs, F ACC, FAHA, CCDS, Vice-Chair, Bruce L. Wilkoff, MD; Ulrika M. Birgersdotter-Green, MD.

TL;DR: There is urgency to evaluate the effectiveness of this potentially-life saving therapeutic strategy at a larger scale, both to treat and cure patients at an early stage before irreversible severe respiratory complications take hold and to decrease duration of carriage and avoid the spread of the disease.

TL;DR: Administration of the HCQ+AZ combination before COVID-19 complications occur is safe and associated with very low fatality rate in patients, retrospectively report on 1061 SARS-CoV-2 positive tested patients.

TL;DR: In this paper, a double-blind, randomized placebo-controlled study was conducted in 29 centers in the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) trial.